CTOs on the Move

Simulation and Training Environment Laboratory

www.sitel.org

 
Simulation and Training Environment Laboratory is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $250-500 Million
  • www.sitel.org
  • 3007 Tilden St NW Ste 3l
    Washington, DC USA 20008
  • Phone: 202.364.5180

Executives

Name Title Contact Details

Similar Companies

Ramp Health

Ramp Health is a company that provides comprehensive healthcare and safety services to employer, health plan, and government clients.

Registered Practical Nurses Association of Ontario

Registered Practical Nurses Association of Ontario is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ellipse Technologies

Ellipse Technologies is a privately held medical device company that is dedicated to the design, development and successful commercialization of non-invasively adjustable, remote controlled implants for a broad spectrum of spinal and orthopedic applications. As part of its product portfolio, the company has developed remote controlled distraction systems using magnets which may eliminate the need for additional surgeries for adjustment. The initial revolutionary products restore proper anatomic position and alignment of the spine and correct limb length discrepancies of the femur and tibia. Ellipse is located in Irvine, California.

BioSig Technologies

BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.

Vinfen Corporation

Vinfen Corporation is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.